Product NDC: | 0067-2053 |
Proprietary Name: | Excedrin |
Non Proprietary Name: | Acetaminophen, Diphenhydramine Citrate |
Active Ingredient(s): | 500; 38 mg/1; mg/1 & nbsp; Acetaminophen, Diphenhydramine Citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0067-2053 |
Labeler Name: | Novartis Consumer Health, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part343 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20100301 |
Package NDC: | 0067-2053-83 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0067-2053-83) > 125 TABLET in 1 BOTTLE, PLASTIC |
NDC Code | 0067-2053-83 |
Proprietary Name | Excedrin |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0067-2053-83) > 125 TABLET in 1 BOTTLE, PLASTIC |
Product NDC | 0067-2053 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Acetaminophen, Diphenhydramine Citrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100301 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Novartis Consumer Health, Inc. |
Substance Name | ACETAMINOPHEN; DIPHENHYDRAMINE CITRATE |
Strength Number | 500; 38 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |